Lan Wei

Pathobiology of liver fibrosis: a translational success story

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease

Hepatocellular carcinoma

Mechanisms of hepatic stellate cell activation

Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma

Hepatic fibrosis: Concept to treatment

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T ₁ -weighted MRI

Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers

CM-101: Type I Collagen–targeted MR Imaging Probe for Detection of Liver Fibrosis

Molecular MRI of collagen to diagnose and stage liver fibrosis